LimFlow Announces First Patient Treated in U.S. Feasibility Study and Commencement of International Post-Market Study

By Natalie GoodridgeJuly 11, 2017October 29th, 2024Healthcare

No Comments

LimFlow Announces First Patient Treated in U.S. Feasibility Study and Commencement of International Post-Market Study

https://www.businesswire.com/news/home/20170711005563/en/LimFlow-Announces-Patient-Treated-U.S.-Feasibility-Study

Tags:

Healthcare LimFlow

PreviousLimFlow Announces Publication of Positive Results from Pilot Study of LimFlow Percutaneous Deep Vein Arterialization (pDVA) System
NextCagent Vascular completes enrolment of PRELUDE study using Serranator Alto device

M&L GROUP

We are a family investment firm that cultivates pioneering ventures into successful enterprises with passion, energy and integrity.

Hospitality

Healthcare

Shipping

Alternatives

Media room

About

Contact

Copyright © 2025 M&L Group. All Rights Reserved. | Legal.

Branding and website design by Stepworks